Option chain shows key data for Belite Bio's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Belite Bio.

Belite Bio (NASDAQ:BLTE) Stock, Option Chain

BELITE BIO INC - ADR

Belite Bio

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

biotech shutter

Analyst Color

Earnings

Analyst Ratings

Tech

BLTE

Belite Bio Inc (NASDAQ: BLTE) stock falls after reporting Q3 net loss of $36.1M; analysts maintain Buy/Overweight rating, citing positive trial results.

Belite Bio Analysts See Potential For Stock Gains With Progress In Key Trials

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AGBA

AGIL

AIXI

AURC

BEDU

BLIN

BSAQ

BTAI

CLAR

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CURO

CWCO

EBIX

ELOX

ERAS

ESGL

FATH

FTRE

FWAC

HRYU

JTAI

LICY

LWAY

Airspan Networks Holdings Inc. Common Stock

MIMO

NAAS

NKLA

ORGN

ORIC

RVLP

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SDPI

SMMT

SNCE

SOUN

SVFD

TDUP

TSHA

VALN

VCIG

VEDU

XXII

YELL

ZYNE

Gainers


	Zynerba Pharmaceuticals, Inc.  (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.


Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

ATUS

AVTX

BBLN

BMEA

BNTC

BPTH

BRSH

BRTX

BTTR

CLGN

DOMA

FEMY

FGEN

FREE

GSRM

HKIT

IMBI

INTA

INVE

INVO

IONQ

IRNT

KBNT

KITT

LCID

LGHL

LVLU

MEDS

MLTX

MRCY

OCFT

PACW

PIRS

SGHC

SIFY

SKLZ

SLGG

SLRN

SRGA

SRRK

WORX

Gainers


	Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.


Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Belite Bio, Inc - American Depositary Shares

Belite Bio Inc

Health Care

Press Releases

Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds

Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results

Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007

Belite Bio Announces Registered Direct Offering of $15 Million

Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects

Belite Bio to Participate in the Leerink Partners Global Healthcare Conference

Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results

Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

ANI Pharmaceuticals

Axsome Therapeutics

BGM Group

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences Hldgs

Indivior

Innoviva

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Liquidia

Ocular Therapeutix

Organon

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pacira BioSciences

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Supernus Pharmaceuticals, Inc. - Common Stock

Supernus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. - Common Stock

Tarsus Pharmaceuticals

Verona Pharma plc - American Depositary Shares

Verona Pharma

Viatris

Benchmark

HC Wainwright & Co.

Maxim Group

SVB Leerink

Comments

Belite Bio

Belite Bio (BLTE) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga